Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Pelvic Neoplasms × Lidocaine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Keratosis, Actinic 3 Squamous Cell Carcinoma of Head and Neck 1 Prostatic Neoplasms 1 Pelvic Neoplasms 1 Pain 1 Oropharyngeal Neoplasms 1 Neoplasms, Cystic, Mucinous, and Serous 1 Glioblastoma 1 Colorectal Neoplasms 1 Carcinoma, Squamous Cell 1 Breast Neoplasms 1 Brain Neoplasms 1 Agnosia 1

Interventions

Vorinostat 1 Sunitinib 1 Lidocaine 1 Ketamine 1 FS 069 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06631625 2024-10-08

Effect of Addition of Dexmedetomidine or Ketamine to Intravenous Infusion of Lidocaine on Proinflammatory Cytokines in Pelvi-abdominal Cancer Surgeries.

Alexandria University

Phase 1 Completed

Pelvic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡